| Typicality: | 0.380 |
| Saliency: | 0.358 |
| in preclinical studies | 8 | location |
| in the lab | 6 | location |
| in improving memory | 5 | transitive-object |
| drug → shown → promising results | 20 |
| drug → show → promising results | 18 |
| drug → be shown → promising results | 6 |
| negative | neutral | positive |
| 0.074 | 0.167 | 0.759 |
| Raw frequency | 44 |
| Normalized frequency | 0.358 |
| Modifier score | 0.700 |
| Perplexity | 126.405 |